extremely significantP <0.001
Data shown in Figure 12a demonstrated that the chimeric 9E10J IgG2a antibody caused an extremely significant survival prolongation ( P <0.001) in comparison with the control group.
Data shown in Figure 12a demonstrated that the chimeric 9E10J IgG2a antibody caused an extremely significant survival prolongation ( P <0.001) in comparison with the control group.